FrancophonIA/ELRC3.0 huggingface dataset:
English: Based on the pharmacological mechanism of action of hydrochlorothiazide its use during the second and third trimester may compromise foeto-placental perfusion and may cause foetal and neonatal effects like icterus, disturbance of electrolyte balance and thrombocytopenia.
Icelandic: Samkvæmt verkunarmáta hýdróklórtíazíðs getur notkun lyfsins á öðrum og síðasta þriðjungi meðgöngu dregið úr blóðflæði milli fylgju og fósturs og valdið áhrifum eins og gulu, truflun á blóðsaltajafnvægi og blóðflagnafæð.
English: Polyethylene Glycol 6000 (Macrogol) Polyethylene Glycol 400 (Macrogol) Iron Oxide Red
Icelandic: Pólýetýlenglýkól 6000 (Makrógól) Pólýetýlenglýkól 400 (Makrógól) Rautt járnoxíð
English: Antidiabetic medicinal products (oral agents and insulins) Dosage adjustment of the antidiabetic medicinal product may be required (see section 4.4);
Icelandic: Sykursýkilyf (til inntöku eða insúlín) Hugsanlega þarf að breyta skömmtum sykursýkilyfja (sjá kafla 4.4);
English: Anaphylactic reactions, toxic epidermal necrolysis, necrotizing angitis (vasculitis, cutaneous vasculitis), cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus erythematosus, photosensitivity reactions, rash, urticaria
Icelandic: bráðaofnæmi, drep í húðþekju, æðabólga með drepi (æðabólga, æðabólga í húð), húðviðbrögð sem líkjast rauðum úlfum, endurvakning rauðra úlfa, ljósnæmi, útbrot, ofsakláði
English: Thiazides, including hydrochlorothiazide, can cause fluid or electrolyte imbalance (hypokalaemia, hyponatraemia, and hypochloremic alkalosis).
Icelandic: Tíazíð og þar með talið hýdróklórtíazíð, geta valdið vökva- eða elektrólýtaröskun (kalíumskorti í blóði, blóðnatríumlækkun og blóðlýtingu samfara lækkun á klóríði).
English: Adequate monitoring of serum potassium in patients at risk is recommended (see section
Icelandic: Hafa skal fullnægjandi eftirlit með kalíum í sermi hjá sjúklingum í áhættuhópum (sjá kafla 4.4).
English: Irbesartan/Hydrochlorothiazide Teva 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide
Icelandic: Irbesartan/Hydrochlorothiazide Teva 300 mg/25 mg filmuhúðaðar töflur irbesartan/hýdróklórtíazíð
English: Hepatic impairment
Icelandic: óeðlileg þvaglát
English: The types and incidences of adverse events reported for patients treated with the combination were similar to the adverse event profile for patients on monotherapy.
Icelandic: Aukaverkanir sem tilkynnt var um hjá sjúklingum sem fengu samsettu lyfjablönduna voru svipaðar og hjá þeim sem fengu einlyfjameðferð hvað varðar gerð og tíðni.
English: • decreases in serum potassium due to hydrochlorothiazide and partly prevented when hydrochlorothiazide was given in combination with irbesartan.
Icelandic: Þessar vefjaskemmdir komu ekki fram hjá makakíöpum; lækkun á kalíum í sermi vegna áhrifa hýdróklórtíazíðs, sem að hluta til var komið í veg fyrir þegar hýdróklórtíazíð var gefið ásamt irbesartani.
English: Although hypokalaemia may develop with the use of thiazide diuretics, concurrent therapy with irbesartan may reduce diuretic-induced hypokalaemia.
Icelandic: Þó að meðferð með tíazíð þvagræsilyfjum geti valdið kalíumskorti í blóði getur samtímis meðferð með irbesartani dregið úr kalíumskorti af völdum þvagræsilyfja.
English: As for any patient receiving diuretic therapy, periodic determination of serum electrolytes should be performed at appropriate intervals.
Icelandic: Elektrólýtaröskun Þegar sjúklingar nota þvagræsilyf á að mæla elektrólýta í sermi með reglulegu millibili.
English: However, another angiotensin-II antagonist affected fertility parameters in animal studies when given alone.
Icelandic: Í dýrarannsóknum hafði hins vegar annar angíótensín-II hemill áhrif á þætti sem tengjast frjósemi þegar hann var gefinn einn sér.
English: Steady-state plasma concentrations are attained within 3 days after initiation of a once-daily dosing regimen.
Icelandic: Jafnvægi á plasmaþéttni næst innan 3 sólarhringa eftir að meðferð með einum skammti á sólarhring hefst.
English: Postural hypotension
Icelandic: Hýdróklórtíazíð
English: Once daily dosing with 150 mg irbesartan and 12.5 mg hydrochlorothiazide gave systolic/diastolic mean placebo-adjusted blood pressure reductions at trough (24 hours post-dosing) of 12.9/6.9 mmHg in patients with mild-to-moderate hypertension.
Icelandic: Við gjöf 150 mg af irbesartani og 12,5 mg af hýdróklórtíazíði einu sinni á sólarhring hjá sjúklingum með vægan eða miðlungi mikinn háþrýsting varð lækkun á slagbils-/þanbilsþrýstingi við lágmarksáhrif lyfsins (24 klst. eftir gjöf) sem nam að meðaltali 12,9/6,9 mm
English: One side of the tablet is debossed with the number “93" and the other side of the tablet is debossed with the number "7238".
Icelandic: Talan „93“ er greypt á aðra hlið töflunnar.
English: Irbesartan/Hydrochlorothiazide Teva 300 mg/25 mg film-coated tablets Each film-coated tablet contains 300 mg of irbesartan and 25 mg of hydrochlorothiazide.
Icelandic: Hver Irbesartan/Hydrochlorothiazide Teva 300 mg/25 mg filmuhúðuð tafla inniheldur 300 mg af irbesartani og 25 mg af hýdróklórtíazíði.
English: Aortic and mitral valve stenosis, obstructive hypertrophic cardiomyopathy As with other vasodilators, special caution is indicated in patients suffering from aortic or mitral stenosis, or obstructive hypertrophic cardiomyopathy.
Icelandic: Ósæðar- og míturlokuþrengsli, hjartavöðvakvilli með útstreymishindrun (obstructive hypertrophic cardiomyopathy)
English: Colestyramine and Colestipol resins
Icelandic: Kólestýramín og kólestipól resín
English: • Irbesartan/Hydrochlorothiazide Teva 150 mg/12.5 mg may be administered in patients whose blood pressure is not adequately controlled with hydrochlorothiazide or irbesartan 150 mg alone;
Icelandic: Irbesartan/Hydrochlorothiazide Teva 150 mg/12,5 mg má gefa sjúklingum ef hýdróklórtíazíð eða 150 mg skammtur af irbesartani einu sér reynist ekki nægjanlegt til að ná stjórn á blóðþrýstingi.
English: When measured by ambulatory blood pressure monitoring, the trough to peak effects of irbesartan/hydrochlorothiazide 150 mg/12.5 mg were 100 %.
Icelandic: Þegar mældur var blóðþrýstingur hjá sjúklingum með fótavist eftir gjöf 150 mg/12,5 mg skammts af irbesartan/hýdróklórtíazíði var munur á lágmarksáhrifum að hámarksáhrifum 100%.
English: There was no evidence of mutagenicity or clastogenicity with the irbesartan/hydrochlorothiazide combination.
Icelandic: Þar sem engar upplýsingar liggja fyrir um notkun Irbesartan/Hydrochlorothiazide
English: In patients with creatinine clearance < 20 ml/min, the elimination half-life of hydrochlorothiazide was reported to increase to 21 hours.
Icelandic: Hjá sjúklingum með kreatínín úthreinsun < 20 ml/mín.
English: There is no clinical experience with Irbesartan/Hydrochlorothiazide Teva in patients with hepatic impairment.
Icelandic: Irbesartan/Hydrochlorothiazide Teva hjá sjúklingum með skerta lifrarstarfsemi.
English: Loop diuretics are preferred to thiazides in this population.
Icelandic: Lyf sem hindra enduruppsog í Henleslykkju (loop diuretica) eru ákjósanlegri handa þessum sjúklingum.
English: Nondepolarizing skeletal muscle relaxants (e.g. tubocurarine) The effect of nondepolarizing skeletal muscle relaxants may be potentiated by hydrochlorothiazide;
Icelandic: Vöðvaslakandi lyf sem ekki eru afskautandi (t.d. túbókúrarín) Verkun vöðvaslakandi lyfja sem ekki eru afskautandi getur aukist við samtímis notkun hýdróklórtíazíðs;
English: Irbesartan/Hydrochlorothiazide Teva 150 mg/12.5 mg film-coated tablets are light pink to pink, film coated capsule shaped tablets.
Icelandic: Irbesartan/Hydrochlorothiazide Teva 150 mg/12,5 mg filmuhúðaðar töflur eru bleikar eða ljósbleikar, filmuhúðaðar hylkislaga töflur.
English: Irbesartan/Hydrochlorothiazide Teva 150 mg/12.5 mg film-coated tablets Each film-coated tablet contains 150 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Icelandic: Hver Irbesartan/Hydrochlorothiazide Teva 150 mg/12,5 mg filmuhúðuð tafla inniheldur 150 mg af irbesartani og 12,5 mg af hýdróklórtíazíði.
English: Pancreatitis, anorexia, diarrhoea, constipation, gastric irritation, sialadenitis, loss of appetite
Icelandic: brisbólga, lystarleysi, niðurgangur, hægðatregða, magaerting, munnvatnskirtlabólga, minnkuð matarlyst
English: There is an increased risk of severe hypotension and renal insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single functioning kidney are treated with angiotensin converting enzyme inhibitors or angiotensin II receptor antagonists.
Icelandic: Aukin áhætta verulegs blóðþrýstingsfalls og skertrar nýrnastarfsemi er hjá sjúklingum með tvíhliða nýrnaslagæðaþrengsli eða þrengsli í nýrnaslagæð þegar um eitt starfhæft nýra er að ræða og sjúklingur er á meðferð með ACE-hemlum eða angíótensín-II blokkum.
English: The administration of a non-steroidal anti-inflammatory drug may reduce the diuretic, natriuretic and antihypertensive effects of thiazide diuretics in some patients;
Icelandic: Samtímis notkun bólgueyðandi gigtarlyfja getur dregið úr þvagræsandi áhrifum, útskilnaði natríums í þvagi og blóðþrýstingslækkandi verkun tíazíð þvagræsilyfja hjá sumum sjúklingum;
English: Each film-coated tablet contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide
Icelandic: Hver filmuhúðuð tafla inniheldur 150 mg af irbesartani og 12,5 mg af hýdróklórtíazíði.
English: Hydrochlorothiazide contained in this medicinal product could produce a positive analytic result in an anti-doping test.
Icelandic: Lyfjapróf Vegna hýdróklórtíazíð innihalds lyfsins geta niðurstöður úr lyfjaprófum orðið ranglega jákvæðar.
English: Irbesartan/Hydrochlorothiazide Teva 150 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Icelandic: Irbesartan/Hydrochlorothiazide Teva 150 mg/12,5 mg töflur irbesartan/hýdróklórtíazíð
English: Exacerbation or activation of systemic lupus erythematosus has been reported with the use of thiazide diuretics.
Icelandic: Tilkynnt hefur verið um að tíazíð þvagræsilyf hafi valdið versnun eða örvun rauðra úlfa (systemic lupus erythematosus).
English: Marked hypercalcaemia may be evidence of hidden hyperparathyroidism.
Icelandic: Ljósnæmisáhrif hydrochlorothiazids geta hugsanlega verið þáttur sem leiðir til húðkrabbameins sem ekki er sortuæxli.
English: Other medicines and Irbesartan/Hydrochlorothiazide Teva
Icelandic: Notkun annarra lyfja samhliða Irbesartan/Hydrochlorothiazide Teva
English: Each film-coated tablet contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide
Icelandic: Hver filmuhúðuð tafla inniheldur 300 mg af irbesartani og 12,5 mg af hýdróklórtíazíði.
English: Povidone
Icelandic: réttstöðusundl
English: Irbesartan/Hydrochlorothiazide Teva 300 mg/12.5 mg film-coated tablets Each film-coated tablet contains 300 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Icelandic: Hver Irbesartan/Hydrochlorothiazide Teva 300 mg/12,5 mg filmuhúðuð tafla inniheldur 300 mg af irbesartani og 12,5 mg af hýdróklórtíazíði.
English: Irbesartan/Hydrochlorothiazide Teva 300 mg/25 mg film-coated tablets are pink to dark pink, film coated capsule shaped tablet.
Icelandic: Irbesartan/Hydrochlorothiazide Teva 300 mg/25 mg filmuhúðaðar töflur eru bleikar eða dökkbleikar, filmuhúðaðar hylkislaga töflur.
English: Irbesartan/Hydrochlorothiazide Teva 300 mg/12.5 mg film-coated tablets are light pink to pink, film coated capsule shaped tablets.
Icelandic: Irbesartan/Hydrochlorothiazide Teva 300 mg/12,5 mg filmuhúðaðar töflur eru bleikar eða ljósbleikar, filmuhúðaðar hylkislaga töflur.
English: • Irbesartan/Hydrochlorothiazide Teva 300 mg/12.5 mg may be administered in patients insufficiently controlled by irbesartan 300 mg or by Irbesartan/Hydrochlorothiazide Teva 150 mg/12.5 mg.
Icelandic: Irbesartan/Hydrochlorothiazide Teva 300 mg/12,5 mg má gefa sjúklingum ef 300 mg af irbesartani eða Irbesartan/Hydrochlorothiazide Teva 150 mg/12,5 mg reynist ekki nægjanlegt til að ná stjórn á blóðþrýstingi.
English: Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors.
Icelandic: Við samtímis gjöf litíums og ACE-hemla hefur verið skýrt frá afturkræfri hækkun á litíumþéttni í sermi og eiturverkunum.
English: Thiazides affect the renal tubular mechanisms of electrolyte reabsorption, directly increasing excretion of sodium and chloride in approximately equivalent amounts.
Icelandic: Tíazíð hafa áhrif á endurupptöku elektrólýta í nýrnapíplum og auka þannig með beinum hætti útskilnað natríums og klóríðs um það bil jafn mikið.
English: Thiazides have been shown to increase the urinary excretion of magnesium, which may result in hypomagnaesemia.
Icelandic: Tíazíð geta aukið útskilnað á magnesíum í þvagi sem getur leitt til magnesíumskorts í blóði.
English: Dual blockade of the renin-angiotensin-aldosterone system (RAAS) There is evidence that the concomitant use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren increases the risk of hypotension, hyperkalaemia and decreased renal function (including acute renal failure).
Icelandic: Vísbendingar eru um að samhliðanotkun ACE hemla, angíótensín II viðtakablokka eða aliskirens auki hættu á blóðþrýstingslækkun, blóðkalíumhækkun og skerðingu á nýrnastarfsemi (þ.m.t. bráðri nýrnabilun).
English: Other interactions
Icelandic: Aðrar milliverkanir
English: Thiazide induced hypokalaemia or hypomagnaesemia favour the onset of digitalis-induced cardiac arrhythmias (see section 4.4);
Icelandic: Kalíumskortur í blóði vegna tíazíðs eða magnesíumskortur geta komið af stað hjartsláttaróreglu af völdum dígitalisnotkunar (sjá kafla 4.4);
English: Irbesartan/Hydrochlorothiazide Teva 300 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Icelandic: Irbesartan/Hydrochlorothiazide Teva 300 mg/12,5 mg filmuhúðaðar töflur irbesartan/hýdróklórtíazíð
English: For therapeutic doses of irbesartan in humans, the hyperplasia/hypertrophy of the renal juxtaglomerular cells does not appear to have any relevance.
Icelandic: Við ráðlagða skammta af irbesartani handa mönnum virðist stækkun frumna nálægt gaukulfrumum ekki hafa neina þýðingu.
English: Electrolyte imbalance (including hypokalaemia and hyponatraemia, see section 4.4), hyperuricaemia, glycosuria, hyperglycaemia, increases in cholesterol and triglycerides
Icelandic: truflun á saltajafnvægi (þ.m.t. lækkun á kalíum í blóði og lækkun á natríum í blóði, sjá kafla 4.4), þvagsýrudreyri, sykurmiga, blóðsykurshækkun, hækkun á kólesteróli og þríglýseríðum
English: Ear and labyrinth disorders
Icelandic: Eyru og völundarhús:
English: The hydrochlorothiazide contained in this medicine could produce a positive result in an anti-doping test.
Icelandic: Vegna hýdróklórtíazíð innihalds lyfsins geta niðurstöður úr lyfjaprófum orðið jákvæðar.
English: Irbesartan/Hydrochlorothiazide Teva is a combination of two active substances, irbesartan and hydrochlorothiazide.
Icelandic: Teva er blanda tveggja virkra efna, irbesartans og hýdróklórtíazíðs.
English: Non-steroidal anti-inflammatory drugs
Icelandic: Hvítar, ógagnsæjar PVC-PVdC
English: These interim limits are based on the maximum daily dose authorised in the EU for each of the sartans and therefore vary between them, as outlined in the table below:
Icelandic: Tíðni aukaverkana sem taldar eru upp hér fyrir neðan er skilgreind á eftirfarandi hátt:
English: When Irbesartan/Hydrochlorothiazide Teva is used in patients with impaired renal function, a periodic monitoring of potassium, creatinine and uric acid serum levels is recommended.
Icelandic: Teva er gefið sjúklingum með skerta nýrnastarfsemi er mælt með reglulegri mælingu á gildum kalíums, kreatíníns og þvagsýru í sermi.
English: Pregnancy
Icelandic: Ungverjaland
English: Irbesartan and its metabolites are eliminated by both biliary and renal pathways.
Icelandic: Brotthvarf irbesartans og umbrotsefna þess er bæði með galli og um nýru.
English: Reproductive system and breast disorders:
Icelandic: Æxlunarfæri og brjóst:
English: Metabolic and endocrine effects
Icelandic: Áhrif á efnaskipti og innkirtla
English: Electrolytes should be monitored during concomitant use.
Icelandic: Fylgjast á með blóðsöltum við þessa samtímis notkun.
English: Non-melanoma skin cancer (Basal cell carcinoma and Squamous cell carcinoma)
Icelandic: húðkrabbamein sem ekki er sortuæxli (grunnfrumukrabbamein og flöguþekjukrabbamein)
English: Similar effects have been very rarely reported with irbesartan so far.
Icelandic: örsjaldan verið greint frá svipuðum áhrifum af irbesartani.
English: Irbesartan does not require metabolic activation for its activity.
Icelandic: Irbesartan þarf ekki að umbrotna til þess að verða virkt.
English: Package leaflet: information for the patient Irbesartan/Hydrochlorothiazide Teva 150 mg/12.5 mg film-coated tablets irbesartan / hydrochlorothiazide
Icelandic: Upplýsingar fyrir notanda lyfsins Irbesartan/Hydrochlorothiazide Teva 150 mg/12,5 mg töflur irbesartan/hýdróklórtíazíð
English: Whereas
Icelandic: Meðganga
English: Hypromellose
Icelandic: Hýprómellósi
English: Candesartan 32
Icelandic: 13. LOTUNÚMER
English: Unless continued AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy.
Icelandic: Sjúklingar sem ráðgera að verða barnshafandi skulu skipta yfir í aðra blóðþrýstingslækkandi meðferð þar sem sýnt hefur verið fram á öryggi á meðgöngu, nema nauðsynlegt sé talið að halda áfram meðferð með angíótensín-II blokkum.
English: Thiazide diuretic-associated azotaemia may occur in patients with impaired renal function.
Icelandic: Aukning köfnunarefnis í blóði tengd tíazíð þvagræsilyfinu getur komið fram hjá sjúklingum með skerta nýrnastarfsemi.
English: The degree to which hydrochlorothiazide is removed by haemodialysis has not been established.
Icelandic: Ekki er vitað að hve miklu leyti hýdróklórtíazíð skilst út með blóðskilun.
English: • Irbesartan/Hydrochlorothiazide Teva 300 mg/25 mg may be administered in patients insufficiently controlled by Irbesartan/Hydrochlorothiazide Teva 300 mg/12.5 mg.
Icelandic: Irbesartan/Hydrochlorothiazide Teva 300 mg/25 mg má gefa sjúklingum ef Irbesartan/Hydrochlorothiazide Teva 300 mg/12,5 mg reynist ekki nægjanlegt til að ná stjórn á blóðþrýstingi.
English: Interstitial nephritis, renal dysfunction
Icelandic: millivefsbólga í nýrum, vanstarfsemi nýrna
English: 6 months toxicity study at irbesartan 90 mg/kg/day, hydrochlorothiazide 90 mg/kg/day, and irbesartan/hydrochlorothiazide 10/10 mg/kg/day.
Icelandic: Eftirtaldar breytingar, sem komu fram í rottum sem fengu 10/10 mg/kg/sólarhring af samsetningu irbesartans/hýdróklórtíazíðs og makakíöpum sem fengu
English: If you get any of these symptoms or get short of breath, stop taking Irbesartan/Hydrochlorothiazide Teva and contact your doctor immediately.
Icelandic: Ef þú færð eitthvert þessarra einkenna eða ef þú átt erfitt með öndun skaltu hætta töku
English: Table 1 gives the adverse reactions observed from spontaneous reporting and in placebo-controlled trials.
Icelandic: Í töflu 1 eru taldar upp aukaverkanir sem greint hefur verið frá eftir markaðssetningu lyfsins og sem komu fram í samanburðarrannsóknum með lyfleysu.
English: Package leaflet: information for the patient Irbesartan/Hydrochlorothiazide Teva 300 mg/25 mg film-coated tablets irbesartan / hydrochlorothiazide
Icelandic: Upplýsingar fyrir notanda lyfsins Irbesartan/Hydrochlorothiazide Teva 300 mg/25 mg filmuhúðaðar töflur irbesartan/hýdróklórtíazíð
English: The trough to peak effects measured by cuff during office visits were 68 % and 76 % for irbesartan/hydrochlorothiazide 150 mg/12.5 mg and irbesartan/hydrochlorothiazide 300 mg/12.5 mg, respectively.
Icelandic: Hlutfall lágmarksáhrifa/hámarksáhrifa (trough to peak) var 68% eftir gjöf irbesartans/hýdróklórtíazíðs150 mg/12,5 mg þegar blóðþrýstingur var mældur með manséttumæli hjá sjúklingum við komu á læknastofu, en 76% eftir gjöf irbesartans/hýdróklórtíazíðs 300 mg/12,5 mg.
English: Psychiatric disorders:
Icelandic: Taugakerfi:
English: Side effects associated with hydrochlorothiazide alone are:
Icelandic: Aukaverkanir sem tengjast hýdróklórtíazíði einu sér
English: Tinnitus
Icelandic: Pólland
English: Package leaflet: information for the patient Irbesartan/Hydrochlorothiazide Teva 300 mg/12.5 mg film-coated tablets irbesartan / hydrochlorothiazide
Icelandic: Upplýsingar fyrir notanda lyfsins Irbesartan/Hydrochlorothiazide Teva 300 mg/12,5 mg töflur irbesartan/hýdróklórtíazíð
English: Prompt medical or surgical treatments may need to be considered if the intraocular pressure remains uncontrolled.
Icelandic: Ef augnþrýstingur er óviðráðanlegur gæti þurft að íhuga tafarlausa lyfjameðferð eða skurðaðgerð.
English: Since Irbesartan/Hydrochlorothiazide Teva contains hydrochlorothiazide, it is not recommended during the first trimester of pregnancy.
Icelandic: Teva inniheldur hýdróklórtíazíð er ekki mælt með notkun þess á fyrsta þriðjungi meðgöngu.
English: The combination of hydrochlorothiazide and irbesartan produces dose-related additive reductions in blood pressure across their therapeutic dose ranges.
Icelandic: Við blöndu hýdróklórtíazíðs og irbesartans í meðferðarskömmtum leggjast skammtaháð blóðþrýstingslækkandi áhrif hvors um sig saman.
English: Therefore, the use of Irbesartan/Hydrochlorothiazide Teva is not recommended.
Icelandic: „Ekki má nota Irbesartan/Hydrochlorothiazide Teva“
English: How to take Irbesartan/Hydrochlorothiazide Teva
Icelandic: Irbesartan/Hydrochlorothiazide Teva
English: See section 4.
Icelandic: Þessi áhrif á 24 klst.
English: Hepatobiliary disorders:
Icelandic: Teva GmbH Tel:
English: if you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren.
Icelandic: Þegar mældur var blóðþrýstingur hjá sjúklingum með fótavist eftir töku
English: Additional information on hydrochlorothiazide interactions When administered concurrently, the following medicinal products may interact with thiazide diuretics:
Icelandic: Viðbótarupplýsingar um milliverkanir við hýdróklórtíazíð Eftirtalin lyf geta milliverkað við tíazíð þvagræsilyf séu þau notuð samtímis:
English: As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk of worsening of renal function, including possible acute renal failure, and an increase in serum potassium, especially in patients with poor pre-existing renal function.
Icelandic: mögulegrar bráðrar nýrnabilunar, og aukningar á kalíum í sermi, sérstaklega hjá sjúklingum sem hafa lélega nýrnastarfsemi fyrir.
English: Irbesartan/Hydrochlorothiazide Teva with alcohol
Icelandic: Irbesartan/Hydrochlorothiazide Teva í ál - álþynnupakkningum:
English: - Tilt your head back.
Icelandic: - Hallaðu höfðinu aftur.
English: Pack of 1 bottle.
Icelandic: Pakkning með 1 glasi.
English: After first opening: 4 weeks.
Icelandic: 2 ár. Eftir fyrstu opnun umbúða: 4 vikur.
English: Povidone (K30)
Icelandic: Póvidón (K30)
English: Asthma*
Icelandic: Astmi*
English: Treatment effect was evaluated up to 29 days.
Icelandic: Meðferðaráhrifin voru metin í allt að 29 daga.
English: Cyclooxygenase 1 (COX-1) is only inhibited to a small extent.
Icelandic: Sýklóoxýgenasa 1 (COX-1) er aðeins hamlað að litlu leyti.
English: - Put yourself in a comfortable and stable position.
Icelandic: - Komdu þér þægilega fyrir í stöðugri stellingu.
English: Do not stop using Yellox without speaking to your doctor.
Icelandic: Hættu ekki að nota Yellox án þess að ræða við lækninn.
English: If it is almost time for the next dose, leave out the missed dose.
Icelandic: Ef það er næstum því kominn tími fyrir næsta skammt þá skaltu sleppa skammtinum sem þú gleymdir.
English: If you use any other eye drops, wait at least five minutes between using Yellox and the other drops.
Icelandic: Ef þú notar einhverja aðra augndropa, láttu þá líða minnst fimm mínútur milli þess sem þú notar Yellox og hina dropana.
English: In vitro, the 99.8% were bound to proteins in human plasma.
Icelandic: In vitro voru 99,8% bundin prótínum í blóðvökva manna.
English: Do not put in any more drops until it is time for your next regular dose.
Icelandic: Settu ekki fleiri dropa í augun fyrr en komið er að næsta venjulega skammti.